What is she best known for?
The fields of study she is best known for:
Her primary areas of investigation include Galectin, Biochemistry, Lectin, Glycan and Stereochemistry.
Her Galectin study results in a more complete grasp of Cell biology.
Her study in Biochemistry concentrates on Glycoconjugate, Ligand, Glycoprotein, Receptor and Glycosylation.
Her C-type lectin study in the realm of Lectin interacts with subjects such as Asialoglycoprotein receptor.
Her biological study spans a wide range of topics, including In vitro, Bovine serum albumin and Targeted drug delivery.
Her Stereochemistry study incorporates themes from Plasma protein binding, Galactose, Fucose, Dioclea grandiflora and Agglutinin.
Her most cited work include:
- Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. (625 citations)
- Chemical biology of the sugar code. (433 citations)
- Galectin-3 Precipitates as a Pentamer with Synthetic Multivalent Carbohydrates and Forms Heterogeneous Cross-linked Complexes (414 citations)
What are the main themes of her work throughout her whole career to date?
Sabine André mostly deals with Galectin, Biochemistry, Lectin, Glycan and Cell biology.
Her Galectin research includes themes of Cell, Galectin-3, Pathology, Molecular biology and Effector.
All of her Biochemistry and Glycoprotein, Glycoconjugate, Agglutinin, Binding site and Plasma protein binding investigations are sub-components of the entire Biochemistry study.
Her study looks at the relationship between Lectin and topics such as Stereochemistry, which overlap with Molecular recognition.
Her Glycan study combines topics in areas such as Sialic acid, Glycosylation and Computational biology.
Much of her study explores Cell biology relationship to Cell growth.
She most often published in these fields:
- Galectin (52.34%)
- Biochemistry (40.50%)
- Lectin (39.25%)
What were the highlights of her more recent work (between 2014-2017)?
- Galectin (52.34%)
- Biochemistry (40.50%)
- Glycan (25.86%)
In recent papers she was focusing on the following fields of study:
Galectin, Biochemistry, Glycan, Lectin and Cell biology are her primary areas of study.
Her Galectin research includes elements of Gene expression profiling, Crystallography, Glycoprotein and Gene, Blot.
Her work on Epitope expands to the thematically related Biochemistry.
Her Glycan study incorporates themes from Glycosylation, Stereochemistry, Computational biology, Peptide and Effector.
Her Lectin study integrates concerns from other disciplines, such as Glycoconjugate, Sequence and Ligand.
Her research integrates issues of Wound healing, Molecular biology, Galectin-3 and Keratinocyte in her study of Cell biology.
Between 2014 and 2017, her most popular works were:
- Dissecting Molecular Aspects of Cell Interactions Using Glycodendrimersomes with Programmable Glycan Presentation and Engineered Human Lectins (70 citations)
- The glycobiology of the CD system: a dictionary for translating marker designations into glycan/lectin structure and function (65 citations)
- Lectins: getting familiar with translators of the sugar code. (56 citations)
In her most recent research, the most cited papers focused on:
Sabine André mainly focuses on Biochemistry, Glycan, Lectin, Galectin and Glycobiology.
Her work on Transmembrane protein and Membrane as part of general Biochemistry study is frequently linked to Linker, bridging the gap between disciplines.
The concepts of her Glycan study are interwoven with issues in Stereochemistry, Agglutinin, Epitope, Computational biology and Binding site.
Her studies in Lectin integrate themes in fields like Vesicle, Glycosylation, Sequence and Effector.
The Glycosylation study combines topics in areas such as Cluster of differentiation, Antigen, Carbohydrate conformation, Glycoconjugate and Monoclonal antibody.
Her Galectin study improves the overall literature in Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
